Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.


Page 1 of 2

LONDON — I‘m window shopping for shares again, and the current market turbulence looks set to throw up a few bargains. Should I pop MELROSE INDUSTRIES PLC ORD 0.1P (LON:MRO) into my basket?

Engineering growth
So you can buy success after all.

Engineering group MELROSE INDUSTRIES PLC ORD 0.1P (LON:MRO) has risen rapidly on acquisitions, with a strategy of buying businesses, improving them, and selling them at a profit. Is there room for share-price improvement? And should I buy in?

Melrose is a relative minnow in FTSE 100 terms, but it has a big appetite. It likes to snap up manufacturing businesses that are failing to live up to their potential, change management focus, generate cash, and sell them on, ideally within three to five years.

Since launch 10 years ago, its private-equity model has generated £2 billion of shareholder value. Its most recent disposal was Truth Hardware, bought in 2008 and sold in May for $200 million cash, which Melrose will use to pay down debt. The company is in the early stages of offloading two other businesses, Crosby and Acco, which Investec analysts expect to be sold at a hefty premium, possibly by the end of this calendar year.

Revenue rising
MELROSE INDUSTRIES PLC ORD 0.1P (LON:MRO) enjoyed a 44% rise in revenue in 2012 to £1.55 billion. Profit before tax rose nearly 39% to £214 million, beating forecasts, which sent the share price up 7%. But after allowing for exceptional items and intangible asset and amortisation, profit before tax fell to £42.9 million, down from £110 million in 2011.

Diluted earnings per share were also lower at 4.3 pence, against 12.9 pence in 2011. However, the final dividend was hiked 4%, giving a full-year dividend of 7.6 pence per share, on a 2.9% yield. Covered 2.2 times, this suggests there is scope for further payout growth.

A 35% earnings drop in 2012 may look odd, but if you make your money from selling businesses, you can’t expect a smooth stream of disposals. Management is particularly excited by its £1.8 billion acquisition of Elster in August 2012, where its improvement plan is one year ahead of schedule.

Earnings are forecast to rise 6% in 2013, and 13% in 2014. By then, the yield is forecast to have risen to 3.3%.

Smelling of roses
MELROSE INDUSTRIES PLC ORD 0.1P (LON:MRO)’s share-price growth has been strong, up 114% over the past three years, and up 180% over five years.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!